# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Acute myeloid leukemia

Acute Non Lymphoblastic Leukemia
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 21-30 of 631 results.
A Study to Evaluate Escalating Doses of ASP1235 (AGS62P1) Given as Monotherapy in Subjects With Acute Myeloid Leukemia (AML)
Status: Recruiting
Last Changed: Apr 26, 2019
First Received: Aug 12, 2016
Disease(s): Acute Myeloid Leukemia
Intervention(s): ASP1235
Locations: Site US00006, Duarte, California, United States
Site US00003, Baltimore, Maryland, United States
Site US00007, Boston, Massachusetts, United States
Site US00009, Boston, Massachusetts, United States
Site US00004, New York, New York, United States
... and 3 other locations.
Dose Escalation Study of Minnelide in Relapsed or Refractory Acute Myeloid Leukemia
Status: Recruiting
Last Changed: Sep 09, 2019
First Received: Nov 30, 2018
Disease(s): Acute Myeloid Leukemia
Intervention(s): Minnelide
Locations: H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Microbiota Changes in Acute Myeloid Leukemia Patients Undergoing Intensive Chemotherapy
Status: Recruiting
Last Changed: Jan 04, 2019
First Received: Nov 02, 2018
Disease(s): Acute Myeloid Leukemia
Intervention(s): Sample Collection Blood, Stool Sample
Locations: Masonic Cancer Center at University of Minnesota, Minneapolis, Minnesota, United States
Long-term Outcomes for Acute Myeloid Leukemia Patients
Status: Not yet recruiting
Last Changed: Jan 28, 2019
First Received: Nov 28, 2018
Disease(s): Acute Myeloid Leukemia
Intervention(s): Questionnaire
Locations: UZ Gasthuisberg, Leuven, Belgium
CHR Citadelle-CHU, Liège, Belgium
University of Liège, Liège, Belgium
KBC Rijeka, Rijeka, Croatia
University Hospital Centre Zagreb, Zagreb, Croatia
... and 40 other locations.
A Dose Optimisation Study of ASLAN003 in Acute Myeloid Leukemia
Status: Recruiting
Last Changed: Jan 11, 2019
First Received: Mar 01, 2018
Disease(s): Acute Myeloid Leukemia
Intervention(s): ASLAN003
Locations: 1 Site, Louisville, Kentucky, United States
1 Site, Albury, New South Wales, Australia
3 Sites, Darlinghurst, New South Wales, Australia
1 Site, Waratah, New South Wales, Australia
1 Site, Douglas, Queensland, Australia
... and 4 other locations.
Randomized Trial of Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia
Status: Recruiting
Last Changed: Sep 17, 2019
First Received: Feb 11, 2019
Disease(s): Acute Myeloid Leukemia
Intervention(s): Gilteritinib, Midostaurin, Daunorubicin, Cytarabine
Locations: MultiCare, Spokane, Washington, United States
UW Cancer Center at ProHealth Care, Waukesha, Wisconsin, United States
Expanded Treatment Protocol for Adults With FLT3-ITD Mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) to Receive Quizartinib
Status: Available
Last Changed: Nov 20, 2018
First Received: Nov 20, 2018
Disease(s): Acute Myeloid Leukemia With Gene Mutations
Intervention(s): Quizartinib Dihydrochloride
Clinical Trial of OPB-111077 in Patients With Relapsed or Refractory Acute Myeloid Leukaemia
Status: Recruiting
Last Changed: Oct 11, 2017
First Received: Jun 23, 2017
Disease(s): Acute Myeloid Leukemia
Intervention(s): OPB-111077
Locations: Hospital 12 Octubre, Madrid, Spain
Hospital Universitario La Fe, Valencia, Spain
Study of Venetoclax in Combination With Decitabine in Subjects With Acute Myeloid Leukemia
Status: Not yet recruiting
Last Changed: Feb 18, 2019
First Received: Feb 18, 2019
Disease(s): Acute Myeloid Leukemia
Intervention(s): Decitabine, Venetoclax
Locations: University Of Chicago Medicine Comprehensive Cancer Center, Chicago, Illinois, United States
Italian Observational Study of Patients With Acute Myeloid Leukemia Treated With Small Molecule Inhibiting BCL-2
Status: Not yet recruiting
Last Changed: Aug 27, 2019
First Received: Aug 27, 2019
Disease(s): Acute Myeloid Leukemia
Locations: European Institute of Oncology, Milano, Italy
Fondazione IRCCS Ca' Granda OSPEDALE MAGGIORE POLICLINICO, Milano, Italy